Daniel Rayson

基本信息

Career Trajectory

Bio

Dr. Rayson’s research interests are in:

clinical trials in breast cancer and gastrointestinal neuroendocrine tumors
breast cancer care path analysis
interval and triple-negative breast cancer
economic analysis of new cancer therapies
translational and clinical research in gastrointestinal neuroendocrine tumors

Research Interests

Papers共 210 篇Author StatisticsCo-AuthorSimilar Experts

By YearBy Citation主题筛选期刊级别筛选合作者筛选合作机构筛选

Is Oncotype DX Testing Informative for Breast Cancers with Low ER Expression? A Retrospective Review from a Biomarker Testing Referral Center

John Loggie,Penelope J. Barnes,Michael D. Carter,Daniel Rayson,Gillian C. Bethune

BREAST (2024)

Cited0Views0WOSBibtex

IND.241: A Canadian Cancer Trials Group Liquid-Biopsy Informed Platform Trial to Evaluate Treatment in CDK4/6-inhibitor Resistant ER +/Her2-Metastatic Breast Cancer

C. Cosci, P. Jamme, V. Kumar,M. B. Nadler,D. Rayson, J. Melvin,M. Rushton,A. Awan,N. Levasseur,S. Chia,P. Bedard,J. Hilton, S. Finn, W. Tu, J. F. Antras,T. J. Unger,D. Cescon,L. Seymour, L. Pearce

EUROPEAN JOURNAL OF CANCER（2024）

Cited0Views0Bibtex

467 (PB455): IND.241: A Canadian Cancer Trials Group Liquid-Biopsy Informed Platform Trial to Evaluate Treatment in CDK4/6-inhibitor Resistant ER +/HER2- Metastatic Breast Cancer

C. Cosci, P. Jamme, V. Kumar,M.B. Nadler,D. Rayson, J. Melvin,M. Rushton,A. Awan,N. Levasseur,S. Chia,P. Bedard,J. Hilton, S. Finn, W. Tu, J.F. Antrás,T.J. Unger,D. Cescon,L. Seymour, L. Pearce

European Journal of Cancer（2024）

Cited0Views0Bibtex

467 (PB455): IND.241: A Canadian Cancer Trials Group Liquid-Biopsy Informed Platform Trial to Evaluate Treatment in CDK4/6-inhibitor Resistant ER +/HER2- Metastatic Breast Cancer

C. Cosci, P. Jamme, V. Kumar,M.B. Nadler,D. Rayson, J. Melvin,M. Rushton,A. Awan,N. Levasseur,S. Chia,P. Bedard,J. Hilton, S. Finn, W. Tu, J.F. Antrás,T.J. Unger,D. Cescon,L. Seymour, L. Pearce

European Journal of Cancer (2024): 114974

Cited0Views0Bibtex

Abstract OT3-26-01: CCTG MA40: DOUBLE-BLIND PLACEBO CONTROLLED PHASE III TRIAL OF FULVESTRANT AND IPATASERTIB FOR ADVANCED HER-2 NEGATIVE AND ESTROGEN RECEPTOR POSITIVE (ER+) BREAST CANCER POST FIRST LINE CDK 4/6 AND AROMATASE INHIBITOR THERAPY (FINER)

Stephen K. Chia,David W. Cescon,Andrew D. Redfern,Danielle Rodin,Christine Simmons,Jean-Pierre Ayoub,Haji Ibrahim Chalchal,Daniel Rayson, Moira Rushton-Marovac,Tracey Hay, Lisa Gallinaro,Bingshu Chen,Wendy Parulekar

Cancer Research（2023）

Cited1Views0Bibtex

Real- world observational study of somatostatin analogues and rescue medication use for neuroendocrine tumors in Canada

D. Rayson, M. Troesch,C. Laforty,M. Badin,A. Liovas, K. Long

JOURNAL OF NEUROENDOCRINOLOGY (2023): 106-106

Cited0Views0Bibtex

Impact of the COVID-19 Pandemic on Medical Oncology Workload: A Provincial Review

Margaret Sheridan,Bruce Colwell,Nathan W. D. Lamond, Robyn Macfarlane,Daniel Rayson,Stephanie Snow,Lori A. Wood,Ravi Ramjeesingh

CURRENT ONCOLOGYno. 3 (2023): 3149-3159

Cited1Views0WOSBibtex

CCTG MA40: DOUBLE-BLIND PLACEBO CONTROLLED PHASE III TRIAL OF FULVESTRANT AND IPATASERTIB FOR ADVANCED HER-2 NEGATIVE AND ESTROGEN RECEPTOR POSITIVE (ER plus ) BREAST CANCER POST FIRST LINE CDK 4/6 AND AROMATASE INHIBITOR THERAPY (FINER)

CANCER RESEARCHno. 5 (2023)

Cited0Views0Bibtex

Reply to Trudeau, M.; Fraser, B. the CADTH Pcodr Expert Review Committee Process Explained. Comment on “rayson Et Al. Access to Neoadjuvant Pertuzumab for HER2 Positive Breast Cancer in Canada: A Dilemma Increasingly Difficult to Explain. Curr. Oncol. 2022, 29, 9891–9895”

Daniel Rayson,Sonal Gandhi,Anil A. Joy,Christine Brezden-Masley,Karen A. Gelmon,Sandeep Sehdev,David Cescon,Stephen Chia

Current Oncology（2023）

Cited2Views0WOSBibtex

Managing the Risk of Lung Toxicity with Trastuzumab Deruxtecan (T-Dxd): A Canadian Perspective

Jan-Willem Henning,Christine Brezden-Masley,Karen Gelmon,Stephen Chia,Shane Shapera,Micheal Mcinnis,Daniel Rayson,Jamil Asselah

Current Oncologyno. 9 (2023): 8019-8038

Cited6Views0WOSBibtex

Author Statistics

Co-Author

Co-Institution

D-Core

合作者
学生
导师

No result temporarily, you can search similar Scholar with the same research interest

Data Disclaimer

The page data are from open Internet sources, cooperative publishers and automatic analysis results through AI technology. We do not make any commitments and guarantees for the validity, accuracy, correctness, reliability, completeness and timeliness of the page data. If you have any questions, please contact us by email: report@aminer.cn

Professor

Papers共 210 篇Author StatisticsCo-AuthorSimilar Experts